Literature DB >> 33223837

Down-Regulation of Hypoxia-Inducible Factor-1α and Downstream Glucose Transporter Protein-1 Gene by β-elemene Enhancing the Radiosensitivity of Lung Adenocarcinoma Transplanted Tumor.

Wenbo Wu1,2, Zhonghui Hu1,3, Qingtao Zhao1, Xiaopeng Zhang1, Hua Zhang1, Huien Wang1, Wenfei Xue1, Lei Yu1, Guochen Duan4.   

Abstract

PURPOSE: To study the effect of β-elemene on the radiosensitivity of A549 cell xenograft tumor and potential mechanisms by which β-elemene regulates the expression of hypoxia-inducible factor-1α (HIF-1α) and glucose transporter protein-1 (GLUT-1).
METHODS: Using an A549 cell transplantation tumor model with male nude mice, we studied the effect of β-elemene on the radiosensitivity of non-small cell lung cancer (NSCLC). The expression of HIF-1α and GLUT-1 was detected by real-time PCR, Western blotting and immunohistochemistry. The relationship between the radiosensitivity of β-elemene and the expression of HIF-1α and GLUT-1 was analyzed.
RESULTS: β-elemene and radiotherapy intervened in the growth of transplanted tumors in varying degrees. The enhancement factor (EF=2.44>1) was calculated; β-elemene at 45 mg/kg had the most significant enhanced effect on radiosensitivity. When β-elemene was used in combination with radiation, the expression of HIF-1α and GLUT-1 was significantly decreased, and there was a positive correlation between the two genes.
CONCLUSION: β-elemene exhibits a radiosensitizing effect on A549 cell xenograft tumor. The underlying molecular mechanism is probably associated with the down-regulation of HIF-1α and GLUT-1 expression, suggesting that β-elemene may directly or indirectly inhibit the expression of HIF-1α and GLUT-1. There is a positive significant correlation between expression of HIF-1α and GLUT-1. HIF-1α and downstream GLUT-1 could be used as a new target for the radiosensitization of NSCLC.
© 2020 Wu et al.

Entities:  

Keywords:  GLUT-1; HIF-1α; radiosensitivity; transplanted tumor; β-elemene

Year:  2020        PMID: 33223837      PMCID: PMC7671467          DOI: 10.2147/OTT.S275956

Source DB:  PubMed          Journal:  Onco Targets Ther        ISSN: 1178-6930            Impact factor:   4.147


  44 in total

1.  A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation.

Authors:  G L Semenza; G L Wang
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

Review 2.  Molecular targets of β-elemene, a herbal extract used in traditional Chinese medicine, and its potential role in cancer therapy: A review.

Authors:  Bingtao Zhai; Nana Zhang; Xuemeng Han; Qiujie Li; Mingming Zhang; Xiaying Chen; Guohua Li; Ruonan Zhang; Peng Chen; Wengang Wang; Chenxi Li; Yu Xiang; Shuiping Liu; Ting Duan; Jianshu Lou; Tian Xie; Xinbing Sui
Journal:  Biomed Pharmacother       Date:  2019-04-06       Impact factor: 6.529

Review 3.  [The role of glucose transporter 1 (GLUT1) in the diagnosis and therapy of tumors].

Authors:  Paweł Jóźwiak; Anna Lipińska
Journal:  Postepy Hig Med Dosw (Online)       Date:  2012-01-04       Impact factor: 0.270

Review 4.  Hypoxia-inducible factor-1 (HIF-1) inhibitors from the last decade (2007 to 2016): A "structure-activity relationship" perspective.

Authors:  Deepak Bhattarai; Xuezhen Xu; Kyeong Lee
Journal:  Med Res Rev       Date:  2017-12-26       Impact factor: 12.944

5.  Inhibition of Glut1 by WZB117 sensitizes radioresistant breast cancer cells to irradiation.

Authors:  Fei Zhao; Jia Ming; Yan Zhou; Linjun Fan
Journal:  Cancer Chemother Pharmacol       Date:  2016-03-24       Impact factor: 3.333

6.  Induction of glucose transporter 1 expression through hypoxia-inducible factor 1alpha under hypoxic conditions in trophoblast-derived cells.

Authors:  Masami Hayashi; Masahiro Sakata; Takashi Takeda; Toshiya Yamamoto; Yoko Okamoto; Kenjiro Sawada; Akiko Kimura; Ryoko Minekawa; Masahiro Tahara; Keiichi Tasaka; Yuji Murata
Journal:  J Endocrinol       Date:  2004-10       Impact factor: 4.286

7.  Downregulation of peroxiredoxin-1 by β-elemene enhances the radiosensitivity of lung adenocarcinoma xenografts.

Authors:  Guoquan Li; Bingbing Xie; Xiaolong Li; Yinghai Chen; Yinghui Xu; Meng Xu-Welliver; Lijuan Zou
Journal:  Oncol Rep       Date:  2015-01-19       Impact factor: 3.906

8.  Assessment of CEP55, PLK1 and FOXM1 expression in patients with bladder cancer in comparison with healthy individuals.

Authors:  Saman Seyedabadi; Massoud Saidijam; Rezvan Najafi; Seyed Habibollah Mousavi-Bahar; Mohammad Jafari; Sajjad MohammadGanji; Ali Mahdavinezhad
Journal:  Cancer Invest       Date:  2018-10-02       Impact factor: 2.176

9.  Expression of hypoxia-induced proteins in ductal carcinoma in situ and invasive cancer of the male breast.

Authors:  Marijn A Vermeulen; Carolien Hm van Deurzen; Carolien P Schroder; John Wm Martens; Paul J van Diest
Journal:  J Clin Pathol       Date:  2019-10-25       Impact factor: 3.411

10.  In vivo evaluation of the effects of simultaneous inhibition of GLUT-1 and HIF-1α by antisense oligodeoxynucleotides on the radiosensitivity of laryngeal carcinoma using micro 18F-FDG PET/CT.

Authors:  Li-Fang Shen; Xin Zhao; Shui-Hong Zhou; Zhong-Jie Lu; Kui Zhao; Jun Fan; Min-Li Zhou
Journal:  Oncotarget       Date:  2017-05-23
View more
  1 in total

1.  HAX1 maintains the glioma progression in hypoxia through promoting mitochondrial fission.

Authors:  Jinghui Lin; Yang Wang; Zhiqing Lin
Journal:  J Cell Mol Med       Date:  2021-11-10       Impact factor: 5.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.